share_log

昭衍新藥:(1)建議採納2022年A股限制性股票激勵計劃;(2)建議根據特別授權發行及授予A股限制性股票涉及關連交易;(3)建議採納2022年A股限制性股票激勵計劃實施考核管理辦法;(4)建議授權董事會處理2022年A股限制性股票激勵計劃相關事項;(5)建議採納2022年A股員工持股計劃

JOINN: (1) Proposed Adoption of the 2022Restricted A Share Incentive Scheme;(2) Proposed Issue and Grant of Restricted A Sharesunder Specific Mandate involving Connected Transaction;(3) Proposed Adoption of the Assessment Administrative Measureson the

HKEX ·  Aug 15, 2022 22:51

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.